1. Large U.S. COVID-19 vaccine trials will exclude pregnant women for now  TODAYonline
  2. Coronavirus: Chinese customs stalls vaccine shipment for trials in Canada  Yahoo Singapore News
  3. Dozens of COVID-19 vaccines are in development. Here are the ones to follow.  National Geographic
  4. COVID-19 Update: PPI Risk, Aerosol Transmission  Medscape
  5. Clinical trial could present a new COVID vaccine strategy  NJTV News
  6. View Full coverage on Google News
CHICAGO - The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters.CHICAGO - The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters.

Large U.S. COVID-19 vaccine trials will exclude pregnant women for now

Clinical trials in Canada of an early Chinese front runner in the race for a coronavirus vaccine are in limbo, with Chinese customs authorities holding up shipment of the injections for weeks.Health Canada gave approval for clinical trials for Ad5-nCoV, a potential vaccine developed jointly by Tianjin-basedClinical trials in Canada of an early Chinese front runner in the race for a coronavirus vaccine are in limbo, with Chinese customs authorities holding up shipment of the injections for weeks.Health Canada gave approval for clinical trials for Ad5-nCoV, a potential vaccine developed jointly by Tianjin-based

Coronavirus: Chinese customs stalls vaccine shipment for trials in Canada

Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.

Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.

Vaccine nationalism: Rich nations spend BILLIONS to grab first anti-coronavirus doses while poor countries are left behind (again) — RT Op-ed

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

COVID-19 vaccine cold war! - The Peninsula Qatar

Three vaccines are in final-stage trials and a fourth is nearly there.Three vaccines are in final-stage trials and a fourth is nearly there.

The Health 202: These are the top coronavirus vaccines to watch - The Washington Post

It's dog eat dog in the world of COVID-19 vaccines.It's dog eat dog in the world of COVID-19 vaccines.

'Vaccine nationalism': Is it every country for itself? - Reuters

The coronavirus stories Medscape''s editors around the globe think you need to know about today.The coronavirus stories Medscape''s editors around the globe think you need to know about today.

COVID-19 Update: PPI Risk, Aerosol Transmission

India News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SIndia News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (S

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate | India News - Times of India

Even if some Americans opt out, the country will still reach herd immunity against COVID-19.Even if some Americans opt out, the country will still reach herd immunity against COVID-19.

People Are Suffering Too Much to Refuse a Vaccine - The Atlantic

WASHINGTON, July 31 — The Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration...WASHINGTON, July 31 — The Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration...

US government to launch 'overwhelming' Covid-19 vaccine campaign by November | World | Malay Mail

The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...

Are Covid Vaccine Stocks Worth Investing In?

Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work. Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.

China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.

A Covid-19 vaccine, amazingly, is close. Why am I so worried? - STAT

AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.

AstraZeneca reports good progress of Covid-19 vaccine in trials

Human challenge trials and equitable distribution of vaccines were extensively discussed in this symposiumHuman challenge trials and equitable distribution of vaccines were extensively discussed in this symposium

Human Challenge Trial For COVID-19 Unnecessary: Anthony Fauci At ICMR Event

AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.

AstraZeneca: Won’t profit from COVID-19 vaccine in pandemic | coronavirus outbreak News,The Indian Express

403 Forbidden

Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.

Commentary: Booster shots will likely be needed even if a COVID-19 vaccine is ready - CNA

CanSino Biologics Inc , one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas if it is to stay in the race, experts say, but it has yet to announce another country willing to help. Mid-stage trials showed that its vaccine did not work as well in people with immunity to a particular strain of the common cold virusCanSino Biologics Inc , one of many companies worldwide trying to develop a coronavirus vaccine, needs to conduct late-stage trials overseas if it is to stay in the race, experts say, but it has yet

Big obstacle: Where can CanSino test vaccine abroad? | Deccan Herald

The vaccine trial that Vice President Mike Pence kicked off in Miami on Monday gives the United States the tiniest chance of being ready to vaccinate millions of Americans just before Election Day. It’s a possibility that fills many public health experts with dread. ADVERTISEMENT Among their concerns: Early evidence that any vaccine works would […]

Experts fear a hasty FDA signoff on vaccine

Vaccine and maternal health experts have argued for years that pregnant women should be included in trials.Vaccine and maternal health experts have argued for years that pregnant women should be included in trials.

Coronavirus: Fears vaccines won't be tested on at-risk pregnant women | Newshub

As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.

COVID-19 Prevention Network seeking volunteers for vaccine clinical trial | abc7.com

KNOXVILLE, Tenn. (WATE) – A coronavirus vaccine trial is now underway in Knoxville and they’re looking for hundreds of volunteers.  Pfizer’s phase two and three study, part of the federal program Operation Warp Speed, aims to get a COVID-19 vaccine to the public as quickly as possible. Doctor William Smith, principal investigator of the study, […]KNOXVILLE, Tenn. (WATE) – A coronavirus vaccine trial is now underway in Knoxville and they’re looking for hundreds of volunteers.  Pfizer’s phase two and three study, part o…

Knoxville coronavirus vaccine trial underway, more volunteers sought | WATE 6 On Your Side

Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem. Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem.

How Americans Became Hesitant About Covid-19 Vaccines: A Q&A With Walter Orenstein - Barron's

Coronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workersCoronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workers

Coronavirus vaccine update: Eyes on India as candidates race towards finish line

Access Denied

By Kate Kelland and Julie Steenhuysen IT’S DOG eat dog in the world of Covid-19 vaccines. That’s the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone,...

'Vaccine nationalism': Is it every country for itself? - Cyprus Mail

'Vaccine nationalism': Is it every country for itself? - Cyprus Mail

New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-19 vaccine, a Health Ministry official said on Friday.New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-19 vaccine, a Health Ministry official said on Friday.

Drug regulator gets committee approval for nod to clinical trials by Serum Institute for Oxford COVID-19 vaccine

Pharmaceutical giant AstraZeneca has promised not to profit from its COVID-19 vaccine, developed in partnership with Oxford University, during the pandemic as the company reported it was on track with late-stage trials for the treatment. AstraZeneca CEO Pascal Soriot made the promise during an online media interaction on Thursday, saying that a vaccine needed to […]

AstraZeneca Promises ‘Not To Profit’ From COVID-19 Vaccine - ODISHA BYTES

Moderna, Pfizer, and AstraZeneca are among the companies developing coronavirus vaccines that could be ready for emergency use soon. In India, two vaccine candidates are being tested on humans.Moderna, Pfizer, and AstraZeneca are among the companies developing coronavirus vaccines that could be ready for emergency use soon. In India, two vaccine candidates are being tested on humans.

Mask, social distancing will be crucial even after Covid-19 vaccine: Scientist - india news - Hindustan Times

Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.

Emerging landscape of COVID-19 vaccines in India as of 31 July: Bharat Biotech, Serum Institute, Zydus at the helm - India News , Firstpost

In a pandemic as serious and widespread as the COVID-19 crisis, hope lies in a vaccine.

What it’s like to be a participant in a COVID-19 vaccine trial | Decaturish - Locally sourced news

COVID vaccine updateCOVID vaccine latest New sCOVID Vaccine COVIDShield COVID Vaccine who will receive first COVId Vaccine india COVID vaccine serum institute COVID vaccine RussiaCOVID-19 Vaccine: Discussions are on whether frontline workers should get the vaccine in India first, as and when it's developed. People with comorbidities, low immunity may get the vaccine after frontline workers.

COVID-19 Vaccine: Who Will Receive First? Frontline Workers? Who Next? Deliberations on in Health Ministry

Coronavirus vaccine is an urgency for the world as COVID-19 cases continue to rise with the United States, Brazil, and India sharing the top 3 positions in terms of maximum cases of the infectious disease. As all vaccines are currently under trial stage, a look at where they stand at present.Coronavirus vaccine is an urgency for the world as COVID-19 cases continue to rise with the United States, Brazil, and India sharing the top 3 positions in terms of maximum cases of the infectious disease. As all vaccines are currently under trial stage, a look at where some of the leading vaccines stand at this point in time.

Coronavirus vaccines final stage trials Oxford Astrazeneca Moderna BioNTECH Pfizer covaxin covishield results performanc | Coronavirus News – India TV

Trusted, accurate and impartial

Misinformation and fake “predicament” in claims about COVID-19 and a vaccine that isn’t available – Australian Associated Press